Marvell Technology (NASDAQ: MRVL), VF Corp. (NYSE: VFC), and Hims & Hers Health (NYSE: HIMS) are three of those names, ...
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...
4h
MarketBeat on MSNDespite Challenges Novo Nordisk Plans to Crush GLP-1 CompetitorsNovo Nordisk A/S (NYSE: NVO) has declared that its GLP-1 drugs for chronic obesity, under the brands Ozempic and Wegovy, are ...
Hims & Hers Health (HIMS) has disclosed plans to shut down Apostrophe, its acne treatment business. This change is part of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results